Paratek Pharmaceuticals, Inc. Quarterly Liabilities, Current in USD from Q4 2010 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Paratek Pharmaceuticals, Inc. quarterly Liabilities, Current history and growth rate from Q4 2010 to Q2 2023.
Paratek Pharmaceuticals, Inc. Liabilities, Current for the quarter ending June 30, 2023 was $203M, a 573% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$203M	+$173M	+573%	Jun 30, 2023	10-Q	2023-08-03
Q1 2023	$32.7M	+$3.91M	+13.6%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$37.4M	+$6.09M	+19.5%	Dec 31, 2022	10-Q	2023-08-03
Q3 2022	$39M	+$9.83M	+33.7%	Sep 30, 2022	10-Q	2022-11-03
Q2 2022	$30.1M	+$9.12M	+43.5%	Jun 30, 2022	10-Q	2022-08-03
Q1 2022	$28.8M	+$5.88M	+25.6%	Mar 31, 2022	10-Q	2022-05-04
Q4 2021	$31.3M	+$7.34M	+30.7%	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$29.2M	+$6.25M	+27.3%	Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$21M	-$12.9M	-38.2%	Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$23M	-$20.2M	-46.7%	Mar 31, 2021	10-Q	2021-05-17
Q4 2020	$24M	-$247K	-1.02%	Dec 31, 2020	10-K	2022-03-14
Q3 2020	$22.9M	-$2.12M	-8.47%	Sep 30, 2020	10-Q	2020-11-05
Q2 2020	$33.9M	+$11.8M	+53.6%	Jun 30, 2020	10-Q	2020-08-10
Q1 2020	$43.1M	+$24.1M	+127%	Mar 31, 2020	10-Q	2020-05-11
Q4 2019	$24.2M	+$6.49M	+36.7%	Dec 31, 2019	10-K	2021-03-29
Q3 2019	$25M	-$678K	-2.64%	Sep 30, 2019	10-Q	2019-11-12
Q2 2019	$22.1M	-$11.9M	-35%	Jun 30, 2019	10-Q	2019-08-06
Q1 2019	$19M	-$4.38M	-18.7%	Mar 31, 2019	10-Q	2019-05-08
Q4 2018	$17.7M	+$920K	+5.48%	Dec 31, 2018	10-K	2020-03-10
Q3 2018	$25.7M	+$9.9M	+62.7%	Sep 30, 2018	10-Q	2018-11-06
Q2 2018	$34M	+$19M	+126%	Jun 30, 2018	10-Q	2018-08-02
Q1 2018	$23.4M	+$4.73M	+25.4%	Mar 31, 2018	10-Q	2018-05-09
Q4 2017	$16.8M	-$3.62M	-17.7%	Dec 31, 2017	10-K	2019-03-06
Q3 2017	$15.8M	-$5.95M	-27.4%	Sep 30, 2017	10-Q	2017-11-08
Q2 2017	$15M	-$13.5M	-47.3%	Jun 30, 2017	10-Q	2017-08-02
Q1 2017	$18.6M	-$7.35M	-28.3%	Mar 31, 2017	10-Q	2017-05-04
Q4 2016	$20.4M	-$90K	-0.44%	Dec 31, 2016	10-K	2018-03-06
Q3 2016	$21.8M	+$8.15M	+59.9%	Sep 30, 2016	10-Q	2016-11-02
Q2 2016	$28.5M	+$17.1M	+151%	Jun 30, 2016	10-Q	2016-08-04
Q1 2016	$26M	+$18.7M	+257%	Mar 31, 2016	10-Q	2016-05-02
Q4 2015	$20.5M	+$16.8M	+448%	Dec 31, 2015	10-K	2017-03-02
Q3 2015	$13.6M	+$11M	+416%	Sep 30, 2015	10-Q	2015-11-12
Q2 2015	$11.4M	+$8.88M	+356%	Jun 30, 2015	10-Q	2015-08-11
Q1 2015	$7.28M	+$5.35M	+276%	Mar 31, 2015	10-Q	2015-05-15
Q4 2014	$3.74M	-$31.1M	-89.3%	Dec 31, 2014	10-K	2016-03-09
Q3 2014	$2.64M	-$421K	-13.8%	Sep 30, 2014	10-Q	2014-10-28
Q2 2014	$2.49M	+$1.14M	+84.5%	Jun 30, 2014	10-Q	2014-08-06
Q1 2014	$1.94M	-$178K	-8.42%	Mar 31, 2014	10-Q	2014-05-05
Q4 2013	$34.8M	+$32.2M	+1208%	Dec 31, 2013	10-K/A	2015-04-24
Q3 2013	$3.06M	-$309K	-9.17%	Sep 30, 2013	10-Q	2013-11-07
Q2 2013	$1.35M	-$1.77M	-56.7%	Jun 30, 2013	10-Q	2013-08-08
Q1 2013	$2.11M	-$483K	-18.6%	Mar 31, 2013	10-Q	2013-05-09
Q4 2012	$2.66M	-$676K	-20.2%	Dec 31, 2012	10-K	2014-03-14
Q3 2012	$3.37M	+$1.03M	+43.9%	Sep 30, 2012	10-Q	2012-11-13
Q2 2012	$3.12M	-$610K	-16.4%	Jun 30, 2012	10-Q	2012-08-13
Q1 2012	$2.6M			Mar 31, 2012	10-Q	2012-05-15
Q4 2011	$3.34M	-$6.31M	-65.4%	Dec 31, 2011	10-K	2013-03-12
Q3 2011	$2.34M			Sep 30, 2011	10-Q	2011-11-10
Q2 2011	$3.73M			Jun 30, 2011	10-Q	2011-08-15
Q4 2010	$9.65M			Dec 31, 2010	10-K	2012-03-30

Previous1Next

Showing 1 to 50 of 50 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.